Annika Berg

Board Member
Annika Carlsson Berg (born 1963), Board Member since 2020.
Nationality: Swedish.

Education/Background: Over 35 years’ experience in pharmaceuticals, biotech, life sciences, and diagnostics, including 24 years in senior positions. Currently Global Vice President of Quality Assurance & Regulatory Affairs, Immunodiagnostics Division, Thermo Fisher Scientific. Previously Global VP of QA/RA and Medical Affairs at Agilent Technologies, Global VP of QA/RA at GE Healthcare, and Section Manager at Pfizer. Licentiate degree in Analytical Chemistry.

Holdings: 44 800 B-Shares, 92 200 LTIP instruments
Independent of the company, its management, and major shareholders.